Aptevo Therapeutics Ownership | Who Owns Aptevo Therapeutics?
Aptevo Therapeutics Ownership Summary
Aptevo Therapeutics is owned by 15.37% institutional investors, and 84.63% retail investors. Fidelity Extended Market Index is the top mutual fund, with 0.33% of its assets in Aptevo Therapeutics shares.
APVO Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Aptevo Therapeutics | 15.37% | - | 84.63% |
| Sector | Healthcare Stocks | 47.38% | 7.99% | 44.63% |
| Industry | Biotech Stocks | 45.43% | 7.81% | 46.75% |
Institutional Shareholders
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2023 | 30 | 15.38% | 1,933,445 | -43.29% | 15 | 0.56% | 12 | 33.33% | 7 | 40.00% |
| Sep 30, 2023 | 26 | 13.04% | 3,409,316 | 267.07% | 52 | 30.06% | 9 | 80.00% | 5 | 150.00% |
| Jun 30, 2023 | 23 | -4.17% | 928,804 | 4.17% | 13 | 8.20% | 5 | -28.57% | 2 | -60.00% |
| Mar 31, 2023 | 24 | -7.69% | 891,596 | -7.44% | 12 | 3.56% | 7 | -46.15% | 5 | -37.50% |
| Dec 31, 2022 | 26 | 30.00% | 963,250 | 11.08% | 18 | 6.51% | 13 | 44.44% | 8 | 166.67% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Extended Market Index | 43.68K | 0.33% | 24.64K |
| Vanguard Institutional Extnd Mkt Idx Tr | 2.08K | 0.02% | - |
| CIMA Global Value SICAV | 14.01K | 0.00% | 11.00 |
| Franklin U.S. Small Cap Equity I | 233.00 | 0.00% | - |
| NT Ext Equity Mkt Idx Fd - NL | 79.00 | 0.00% | - |
| NT Quality Small Cap Core | 78.00 | 0.00% | - |
| NT Quality SCC US Fund - L | 78.00 | 0.00% | -1.00 |
| NT Ext Equity Mkt Idx Fd - DC - NL - T2 | 64.00 | 0.00% | - |
| BNYM Mellon SL Market Completion UC1 | 37.00 | 0.00% | - |
| SSgA U.S. Total Market Index Strategy | 7.00 | 0.00% | 2.00 |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q3 | - | - |
| 2024 Q2 | - | - |
| 2024 Q1 | - | - |
| 2023 Q3 | - | - |
| 2023 Q2 | - | - |
APVO Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools